Matches in Wikidata for { <http://www.wikidata.org/entity/Q63577219> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63577219 description "clinical trial" @default.
- Q63577219 description "ensayu clínicu" @default.
- Q63577219 description "klinisch onderzoek" @default.
- Q63577219 description "клінічне випробування" @default.
- Q63577219 name "A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma" @default.
- Q63577219 type Item @default.
- Q63577219 label "A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma" @default.
- Q63577219 prefLabel "A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma" @default.
- Q63577219 P1050 Q63577219-9A301928-4524-4B8A-A7E2-D9EFD58FB349 @default.
- Q63577219 P1132 Q63577219-79D58612-9E5C-4B46-AAAC-EA4144FDEBA0 @default.
- Q63577219 P1476 Q63577219-CF3D8B18-27FE-48A1-9FFF-06A32972E487 @default.
- Q63577219 P17 Q63577219-245A050E-055E-4FDE-AACB-1EA8BC4D4C74 @default.
- Q63577219 P17 Q63577219-A1206552-37A4-4348-9471-4995D2AC883D @default.
- Q63577219 P17 Q63577219-E4373C08-0E6D-4FAB-A51C-5742DF972DE8 @default.
- Q63577219 P17 Q63577219-F08C0D31-F334-475D-ACC0-1428B890A2A8 @default.
- Q63577219 P17 Q63577219-F131B145-F6AE-4350-B9B3-19F1B64153F1 @default.
- Q63577219 P2899 Q63577219-FE838F74-75BC-4355-A1F7-8715C944E02A @default.
- Q63577219 P3098 Q63577219-32963D50-6908-448D-BB85-AD24EF02E187 @default.
- Q63577219 P31 Q63577219-9D633818-6AF2-4F85-9AAC-ACBD38E39129 @default.
- Q63577219 P4844 Q63577219-EB687A82-A658-467E-8DD2-04E949DCE989 @default.
- Q63577219 P580 Q63577219-0725B43B-BCB2-4BEF-8EA5-B2F56DC68068 @default.
- Q63577219 P582 Q63577219-557984C5-36C1-4725-9E9E-EB28DBA32564 @default.
- Q63577219 P6099 Q63577219-B5D2B229-58FF-4D3B-BD15-942BE437FC24 @default.
- Q63577219 P8363 Q63577219-6C008CC0-D4A2-4715-BABC-6FA14A6F53C6 @default.
- Q63577219 P859 Q63577219-DA48E308-A008-400F-9F88-FB94B6DD153D @default.
- Q63577219 P1050 Q208414 @default.
- Q63577219 P1132 "+54" @default.
- Q63577219 P1476 "A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma" @default.
- Q63577219 P17 Q142 @default.
- Q63577219 P17 Q183 @default.
- Q63577219 P17 Q30 @default.
- Q63577219 P17 Q38 @default.
- Q63577219 P17 Q408 @default.
- Q63577219 P2899 "+18" @default.
- Q63577219 P3098 "NCT02961881" @default.
- Q63577219 P31 Q30612 @default.
- Q63577219 P4844 Q410189 @default.
- Q63577219 P580 "2017-09-18T00:00:00Z" @default.
- Q63577219 P582 "2021-05-16T00:00:00Z" @default.
- Q63577219 P6099 Q5452194 @default.
- Q63577219 P8363 Q78089383 @default.
- Q63577219 P859 Q470517 @default.